Biocon board approves sale of branded formulations business to subsidiary

The Board of Directors in its meeting approved the sale of Branded Formulations India (BFI) business to Biocon Biologics India (BBIL).

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2WJIe5D
via IFTTT

0 comments:

Post a Comment